NO20050801L - Prodrug av protonpumpe inhibitorer - Google Patents
Prodrug av protonpumpe inhibitorerInfo
- Publication number
- NO20050801L NO20050801L NO20050801A NO20050801A NO20050801L NO 20050801 L NO20050801 L NO 20050801L NO 20050801 A NO20050801 A NO 20050801A NO 20050801 A NO20050801 A NO 20050801A NO 20050801 L NO20050801 L NO 20050801L
- Authority
- NO
- Norway
- Prior art keywords
- proton pump
- pump inhibitors
- prodrug
- prodrugs
- bioavailability
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39745902P | 2002-07-19 | 2002-07-19 | |
PCT/US2003/022419 WO2004009583A2 (fr) | 2002-07-19 | 2003-07-15 | Promedicaments des inhibiteurs de la pompe a protons |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050801L true NO20050801L (no) | 2005-02-15 |
Family
ID=30771064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050801A NO20050801L (no) | 2002-07-19 | 2005-02-15 | Prodrug av protonpumpe inhibitorer |
Country Status (23)
Country | Link |
---|---|
US (3) | US6897227B2 (fr) |
EP (1) | EP1556371B1 (fr) |
JP (1) | JP4463103B2 (fr) |
KR (2) | KR100788778B1 (fr) |
AT (1) | ATE323695T1 (fr) |
AU (1) | AU2003259154B2 (fr) |
BR (1) | BR0312802A (fr) |
CA (1) | CA2492718C (fr) |
CO (1) | CO5690576A2 (fr) |
DE (1) | DE60304726T2 (fr) |
DK (1) | DK1556371T3 (fr) |
ES (1) | ES2263028T3 (fr) |
HK (1) | HK1079207A1 (fr) |
IL (1) | IL166371A0 (fr) |
MX (1) | MXPA05000657A (fr) |
NO (1) | NO20050801L (fr) |
NZ (1) | NZ538221A (fr) |
PL (1) | PL375255A1 (fr) |
PT (1) | PT1556371E (fr) |
RU (1) | RU2292342C2 (fr) |
TW (1) | TW200502231A (fr) |
WO (1) | WO2004009583A2 (fr) |
ZA (1) | ZA200501116B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
CA2493618A1 (fr) * | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation |
BRPI0412590A (pt) * | 2003-07-15 | 2006-09-19 | Allergan Inc | processo para preparação de pró-drogas isomericamente puras de inibidores de bomba de próton |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20060241037A1 (en) * | 2003-10-03 | 2006-10-26 | Allergan Inc. | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs |
EP1715861A2 (fr) * | 2004-02-18 | 2006-11-02 | Allergan, Inc. | Methodes et compositions d'administration de promedicaments d'inhibiteurs de la pompe a protons |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
BRPI0507796A (pt) * | 2004-03-11 | 2007-07-17 | Allergan Inc | métodos e composições para o tratamento de condições relacionadas com a secreção de ácido gástrico |
DK1740571T3 (da) | 2004-04-28 | 2009-11-02 | Hetero Drugs Ltd | Fremgangsmåde til fremstilling af pyridinylmethyl-1H-benzimidazolforbindelser i enantiomerisk beriget form eller som enkelte enantiomerer |
WO2007073301A1 (fr) * | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Derives du benzoimidazole en tant que promedicaments d'inhibiteurs de la pompe a protons |
WO2007081871A1 (fr) * | 2006-01-10 | 2007-07-19 | Allergan, Inc. | Procedes et compositions de sels therapeutiques |
NZ572007A (en) * | 2006-05-09 | 2010-12-24 | Astrazeneca Ab | Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
US20070293543A1 (en) * | 2006-06-19 | 2007-12-20 | Edward Lee | THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z |
US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
US20100113524A1 (en) * | 2006-09-19 | 2010-05-06 | Garst Michael E | Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety |
WO2009044976A1 (fr) * | 2007-10-05 | 2009-04-09 | Lg Electronics Inc. | Dispositif d'affichage à plasma |
KR20090035195A (ko) * | 2007-10-05 | 2009-04-09 | 엘지전자 주식회사 | 플라즈마 디스플레이 장치 |
KR100895333B1 (ko) * | 2007-11-01 | 2009-05-07 | 엘지전자 주식회사 | 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치 |
EP2627178B1 (fr) | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Composés de type quinazolinone convenant comme antagonistes de crth2 |
AU2011349524B2 (en) | 2010-12-23 | 2016-06-02 | Merck Sharp & Dohme Corp. | Quinoxalines and aza-quinoxalines as CRTH2 receptor modulators |
EP2661265B1 (fr) | 2010-12-23 | 2017-03-08 | Merck Sharp & Dohme Corp. | Quinoléines et aza-quinoléines en tant que modulateurs de l'activité du récepteur crth2 |
CN107405338A (zh) * | 2015-01-09 | 2017-11-28 | 加州大学评议会 | 用于治疗胃肠道感染的组合物和方法 |
CN108997177A (zh) * | 2018-09-04 | 2018-12-14 | 邵阳学院 | 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US430042A (en) * | 1890-06-10 | Valve | ||
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
US4758597A (en) * | 1987-05-15 | 1988-07-19 | University Patents, Inc. | Carenadiol and derivatives |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
US5045522A (en) * | 1990-03-27 | 1991-09-03 | Phillips Petroleum Company | Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams |
ES2140391T3 (es) * | 1990-06-20 | 2000-03-01 | Astra Ab | Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico. |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
PL181801B1 (pl) * | 1994-06-10 | 2001-09-28 | Byk Gulden Lomberg Chem Fab | Podstawione aryloalkilotioalkilotiopirydyny do zwalczania bakterii Helicobacter oraz srodek leczniczy zawierajacy podstawione aryloalkilotioalkilotiopirydyny PL |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
ES2192394T3 (es) * | 1998-08-10 | 2003-10-01 | Winston Pharmateuticals Llc | Profarmacos de inhibidores de la bomba de protones. |
ES2232169T3 (es) * | 1998-08-12 | 2005-05-16 | Gilead Sciences, Inc. | Procedimiento de fabricacion de nucleosidos de 1,3-oxatiolano. |
SE0002476D0 (sv) | 2000-06-30 | 2000-06-30 | Astrazeneca Ab | New compounds |
US6599167B2 (en) * | 2000-09-27 | 2003-07-29 | Glenn Waltz | Game call holder and amplifying device |
WO2002030920A1 (fr) * | 2000-10-12 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Composes derives de benzimidazole, leur procede de production et leur utilisation |
-
2003
- 2003-07-15 KR KR1020057000899A patent/KR100788778B1/ko not_active IP Right Cessation
- 2003-07-15 KR KR1020067026729A patent/KR100822981B1/ko not_active IP Right Cessation
- 2003-07-15 JP JP2004523537A patent/JP4463103B2/ja not_active Expired - Fee Related
- 2003-07-15 MX MXPA05000657A patent/MXPA05000657A/es active IP Right Grant
- 2003-07-15 DE DE60304726T patent/DE60304726T2/de not_active Expired - Lifetime
- 2003-07-15 PT PT03765694T patent/PT1556371E/pt unknown
- 2003-07-15 PL PL03375255A patent/PL375255A1/xx not_active Application Discontinuation
- 2003-07-15 RU RU2005105564/04A patent/RU2292342C2/ru not_active IP Right Cessation
- 2003-07-15 BR BR0312802-4A patent/BR0312802A/pt not_active IP Right Cessation
- 2003-07-15 WO PCT/US2003/022419 patent/WO2004009583A2/fr active IP Right Grant
- 2003-07-15 AU AU2003259154A patent/AU2003259154B2/en not_active Ceased
- 2003-07-15 US US10/620,252 patent/US6897227B2/en not_active Expired - Lifetime
- 2003-07-15 ES ES03765694T patent/ES2263028T3/es not_active Expired - Lifetime
- 2003-07-15 DK DK03765694T patent/DK1556371T3/da active
- 2003-07-15 CA CA2492718A patent/CA2492718C/fr not_active Expired - Lifetime
- 2003-07-15 AT AT03765694T patent/ATE323695T1/de not_active IP Right Cessation
- 2003-07-15 EP EP03765694A patent/EP1556371B1/fr not_active Expired - Lifetime
- 2003-07-15 NZ NZ538221A patent/NZ538221A/en unknown
- 2003-11-07 TW TW092131253A patent/TW200502231A/zh unknown
-
2005
- 2005-01-18 IL IL16637105A patent/IL166371A0/xx unknown
- 2005-01-20 US US11/039,630 patent/US20050182101A1/en not_active Abandoned
- 2005-01-20 US US11/039,631 patent/US20050143423A1/en not_active Abandoned
- 2005-02-08 ZA ZA200501116A patent/ZA200501116B/xx unknown
- 2005-02-15 CO CO05013468A patent/CO5690576A2/es not_active Application Discontinuation
- 2005-02-15 NO NO20050801A patent/NO20050801L/no not_active Application Discontinuation
-
2006
- 2006-01-11 HK HK06100445A patent/HK1079207A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050801L (no) | Prodrug av protonpumpe inhibitorer | |
NO20055135L (no) | Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer | |
NO20091395L (no) | Nye tiofenderivater | |
NO20082793L (no) | Nye tiofenderivater | |
NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
DE60210944D1 (de) | N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten | |
NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
NO20064077L (no) | Kemokinreseptorantagonister | |
NO20075298L (no) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
WO2005110410A3 (fr) | Inhibiteurs de kinases en tant qu'agents therapeutiques | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
DK1784404T3 (da) | Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling | |
NO20066055L (no) | Pyridinderivater | |
NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
DK2263674T3 (da) | 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20080554L (no) | Pyrazolonderivater | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
NO20084543L (no) | Benzimidazolderivater | |
DE60027144D1 (de) | Hydroxamsäure-derivate | |
NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. | |
NO20001781L (no) | 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse | |
DK1513800T3 (da) | Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse | |
EP1650194A4 (fr) | Inhibiteur de la proteine kinase | |
NO20054721L (no) | Substituerte anilinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |